151 related articles for article (PubMed ID: 25765773)
1. A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.
Cuervo G; Puig-Asensio M; Garcia-Vidal C; Fernández-Ruiz M; Pemán J; Nucci M; Aguado JM; Salavert M; González-Romo F; Guinea J; Zaragoza O; Gudiol C; Carratalà J; Almirante B; ;
Clin Microbiol Infect; 2015 Jul; 21(7):684.e1-9. PubMed ID: 25765773
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
[TBL] [Abstract][Full Text] [Related]
4. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.
Fernández-Ruiz M; Guinea J; Lora-Pablos D; Zaragoza Ó; Puig-Asensio M; Almirante B; Cuenca-Estrella M; Aguado JM; ;
Clin Microbiol Infect; 2017 Sep; 23(9):672.e1-672.e11. PubMed ID: 28143788
[TBL] [Abstract][Full Text] [Related]
5. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.
Gamaletsou MN; Walsh TJ; Zaoutis T; Pagoni M; Kotsopoulou M; Voulgarelis M; Panayiotidis P; Vassilakopoulos T; Angelopoulou MK; Marangos M; Spyridonidis A; Kofteridis D; Pouli A; Sotiropoulos D; Matsouka P; Argyropoulou A; Perloretzou S; Leckerman K; Manaka A; Oikonomopoulos P; Daikos G; Petrikkos G; Sipsas NV
Clin Microbiol Infect; 2014 Jan; 20(1):O50-7. PubMed ID: 23889746
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.
Puig-Asensio M; Ruiz-Camps I; Fernández-Ruiz M; Aguado JM; Muñoz P; Valerio M; Delgado-Iribarren A; Merino P; Bereciartua E; Fortún J; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2015 May; 21(5):491.e1-10. PubMed ID: 25703212
[TBL] [Abstract][Full Text] [Related]
7. Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel.
Ben-Ami R; Rahav G; Elinav H; Kassis I; Shalit I; Gottesman T; Megged O; Weinberger M; Ciobotaro P; Shitrit P; Weber G; Paz A; Miron D; Oren I; Bishara J; Block C; Keller N; Kontoyiannis DP; Giladi M;
Clin Microbiol Infect; 2013 Aug; 19(8):752-6. PubMed ID: 23005038
[TBL] [Abstract][Full Text] [Related]
8. [Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population].
García-Rodríguez J; Cantón E; Pemán J; Alvarez M; Ezpeleta G; Gómez-Nieto A; Iglesias I; Martín-Mazuelos E; Ramírez-de Ocariz I; Rezusta A; Royo-García G;
Enferm Infecc Microbiol Clin; 2013; 31(6):363-8. PubMed ID: 23398860
[TBL] [Abstract][Full Text] [Related]
9. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
[TBL] [Abstract][Full Text] [Related]
11. Candida auris candidaemia in Indian ICUs: analysis of risk factors.
Rudramurthy SM; Chakrabarti A; Paul RA; Sood P; Kaur H; Capoor MR; Kindo AJ; Marak RSK; Arora A; Sardana R; Das S; Chhina D; Patel A; Xess I; Tarai B; Singh P; Ghosh A
J Antimicrob Chemother; 2017 Jun; 72(6):1794-1801. PubMed ID: 28333181
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
[TBL] [Abstract][Full Text] [Related]
13. Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain.
Rodríguez D; Almirante B; Cuenca-Estrella M; Rodríguez-Tudela JL; Mensa J; Ayats J; Sanchez F; Pahissa A;
Clin Microbiol Infect; 2010 Nov; 16(11):1676-82. PubMed ID: 20219079
[TBL] [Abstract][Full Text] [Related]
14. Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection.
Brosh-Nissimov T; Ben-Ami R
Clin Microbiol Infect; 2015 Nov; 21(11):1011-7. PubMed ID: 26183300
[TBL] [Abstract][Full Text] [Related]
15. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
Oxman DA; Chow JK; Frendl G; Hadley S; Hershkovitz S; Ireland P; McDermott LA; Tsai K; Marty FM; Kontoyiannis DP; Golan Y
J Antimicrob Chemother; 2010 Jul; 65(7):1460-5. PubMed ID: 20430790
[TBL] [Abstract][Full Text] [Related]
16. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.
Colombo AL; Garnica M; Aranha Camargo LF; Da Cunha CA; Bandeira AC; Borghi D; Campos T; Senna AL; Valias Didier ME; Dias VC; Nucci M
Med Mycol; 2013 Jan; 51(1):38-44. PubMed ID: 22762208
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
[TBL] [Abstract][Full Text] [Related]
18. Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.
Keighley C; Chen SC; Marriott D; Pope A; Chapman B; Kennedy K; Bak N; Underwood N; Wilson HL; McDonald K; Darvall J; Halliday C; Kidd S; Nguyen Q; Hajkowicz K; Sorrell TC; Van Hal S; Slavin MA
BMC Infect Dis; 2019 May; 19(1):445. PubMed ID: 31113382
[TBL] [Abstract][Full Text] [Related]
19. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort.
López-Cortés LE; Almirante B; Cuenca-Estrella M; Garnacho-Montero J; Padilla B; Puig-Asensio M; Ruiz-Camps I; Rodríguez-Baño J;
Clin Microbiol Infect; 2016 Aug; 22(8):733.e1-8. PubMed ID: 27189197
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.
Shah DN; Yau R; Weston J; Lasco TM; Salazar M; Palmer HR; Garey KW
J Antimicrob Chemother; 2011 Sep; 66(9):2146-51. PubMed ID: 21700622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]